54 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
15509155	5	NO-sartans: a new class of pharmacodynamic hybrids as cardiovascular drugs.	Universit£
9379447	20	Angiotensin analogues palmitoylated in positions 1 and 4.	Universit£
	19	Substituted lactam biphenyltetrazoles as angiotensin II mediated antihypertensives	TBA
	40	Synthesis and In Vitro evaluation of fused ring heterocyle-containing angiotensin II antagonists.	TBA
22727371	22	Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT1 receptor antagonists.	School of Chemical Engineering & The Environment
18318468	39	Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.	Universit£
10821712	18	Quantized surface complementarity diversity (QSCD): a model based on small molecule-target complementarity.	Neogenesis
8576904	78	Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.	Dupont Pharmaceuticals
8340909	14	Excursions in drug discovery.	Merck Research Laboratories
	32	L-161,638: A potent AT2selective quinazolinone angiotensin II binding inhibitor	TBA
	17	(6-oxo-3-pyridazinyl)-benzimidazoles as potent angiotensin II receptor antagonists	TBA
22264484	28	Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.	Kyung Hee University
22309912	28	Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.	Beijing Institute of Technology
21071232	78	Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.	The M. S. University of Baroda
	24	The design, binding affinity prediction and synthesis of macrocyclic angiotensin II AT1 and AT2 receptor antagonists	TBA
	10	L-162,389: a potent orally active angiotensin II receptor antagonist with balanced affinity to both AT1 and AT2 receptor subtypes	TBA
	17	AT1 selective angiotensin II antagonists with phenoxyphenylacetic acid as a biphenyl replacement part I	TBA
	60	The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptors	TBA
	54	α-Phenoxyphenylacetic acid derived angiotensin II antagonists with low nanomolar AT1/AT2 receptor subtype affinity (Part II)	TBA
	8	Substituted 1,3-benzodioxole & 1,3-benzodithiole -2- carboxylates and their tetrazole analogs with potent binding affinity to the angiotensin II AT1 receptor	TBA
	56	Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypes	TBA
	134	Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes.	TBA
	54	A new class of balanced AT1/AT2 angiotensin II antagonists: quinazolinone AII antagonists with acylsulfonamide and sulfonylcarbamate acidic functionalities	TBA
	36	Quinazolinone Biphenyl Acylsulfonamides: A potent new class of angiotensin-II receptor antagonists	TBA
	50	Potent imidazole angiotensinII antagonists: acyl sulfonamides and acyl sulfamides as tetrazole replacements	TBA
	10	Evaluation of heterocyclic acid equivalents as tetrazole replacements in imidazopyridine-based nonpeptide angiotensin II receptor antagonists	TBA
	8	Synthesis of new imidazo[1,2-b]pyridazine isosteres of potent imidazo[4,5-b]pyridine angiotensin II antagonists	TBA
	22	Acidic phenols: a new class of potent nonpeptide angiotensin II receptor antagonists	TBA
	24	Subtituted phenylthiophene benzoylsulfonamides with potent binding affinity to angiotensin II AT1 and AT2 receptors	TBA
	42	Imidazo[4,5-b]pyridine-based AT1 / AT2 angiotensin II receptor antagonists	TBA
	19	Triazolinones as nonpeptide angiotensin II antagonists. 2. discovery of a potent and orally active triazolinone acylsulfonamide	TBA
	10	Angiotensin II receptor antagonists containing a phenylpyridine element.	TBA
	45	Quinazolinones 2: QSAR and in vivo characterization of AT1 selective AII antagonists	TBA
	23	Quinazolinones 1: design and synthesis of potent quinazolinone- containing AT1-selective angiotensin-II receptor antagonists	TBA
	56	Synthesis and structure-activity relationships of a novel series of non-peptide AT2-selective angiotensin II receptor antagonists	TBA
17412584	26	Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.	China Pharmaceutical University
17064065	6	Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds.	Università
8496939	100	Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.	Merck Research Laboratories
8355255	103	Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones.	Merck Research Laboratories
8277506	58	Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides.	Merck Research Laboratories
8277505	58	Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.	Merck Research Laboratories
8246245	26	(Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists.	Merck Research Laboratories
8246227	57	Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.	Merck Research Laboratories
8230109	18	A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor.	Merck Research Laboratories
8064808	202	Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity.	Merck Research Laboratories
7990105	16	A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonist.	Merck Research Laboratories
7799397	86	Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypes.	Merck Research Laboratories
7562905	258	Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes.	Merck Research Laboratories